Patients with a chief complaint of craniofacial pain (migraine, cluster headache, trigeminal autonomic cephalgia, sphenopalatine ganglioneuraligia, paroxysmal hemicrania) who has Stanford Pain \& ENT clinic visit
You may not be if
age \<18 or \>80
pregnant women
economically disadvantaged (not able to afford clinic visits/treatments)
decisionally impaired (unable to obtain informed consent)
has allergy to bupivacaine
unable or unwilling to participate plans to participate in another clinical study at any time during this study
Clareo Health | Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
